Product Information
SUMATRIPTAN SUCC 100 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.4309 per EA under NDC 00378563259. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Aug 10, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378563259
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
SUMATRIPTAN SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA077744FDA Approved
8/10/2009
TE Code
AB
On Market Since
8/10/2009
Pharmacological Classes
Price Statistics
The NADAC for SUMATRIPTAN SUCC 100 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 54.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4309 per EA |
|---|---|
| All-time high | $1.0526 (Mar 11, 2015) |
| All-time low | $0.3720 (Nov 20, 2024) |
| 52-week high | $0.4721 |
| 52-week low | $0.4309 |
| Median price | $0.5837 |
| Average price | $0.6238 |
| Largest weekly change | -23.3% (Nov 20, 2024) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SUMATRIPTAN SUCC 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SUMATRIPTAN SUCC 100 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.4309 per EA (NDC 00378563259), effective Aug 19, 2026.
How has the price of SUMATRIPTAN SUCC 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for SUMATRIPTAN SUCC 100 MG TABLET has declined 54.1%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SUMATRIPTAN SUCC 100 MG TABLET?
Since Nov 28, 2013, the NADAC for SUMATRIPTAN SUCC 100 MG TABLET has ranged from a low of $0.3720 (Nov 20, 2024) to a high of $1.0526 (Mar 11, 2015), with a median of $0.5837 per EA.
Are there cheaper alternatives to SUMATRIPTAN SUCC 100 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as SUMATRIPTAN SUCC 100 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures SUMATRIPTAN SUCC 100 MG TABLET?
SUMATRIPTAN SUCC 100 MG TABLET (NDC 00378563259) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.